What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

Author: Schellhammer P.F.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.4, Iss.3, 1998-05, pp. : 73-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content